South Korea-Based UNDBIO Plans Morgantown, West Virginia, Insulin Manufacturing Complex
04/20/2023
The company secured a lease with West Virginia University and will work to receive FDA approval for the product.
"The mission of UNDBIO is to develop and produce state-of-the-art insulin in West Virginia,” UNDBIO Chairman Caleb Jun said. “Our products will save human lives and improve the quality of life for those afflicted with diabetes. We are excited to see West Virginia become a mecca for manufacturing highly advanced insulin to treat diabetic patients around the world."
UNDBIO is the only Korean pharmaceutical company to provide a complete Diabetes care Solution by offering high-quality affordable Insulin, Insulin Analogs to meet the unmet need of diabetes patients.
“I join the Governor in expressing my excitement for this announcement today,” Secretary of the West Virginia Department of Commerce Mitch Carmichael noted. “This announcement, this company, this investment, and the potential for so many jobs for our hardworking West Virginians makes for a very great day. Good things are on the horizon, this is just the beginning!”
Project Announcements
GE Appliances Expands Jefferson County, Kentucky, Operations
06/30/2025
ValorFlex Packaging Plans Bowling Green, Kentucky, Production Operations
06/30/2025
Neuro.io Plans Terrebonne Parish, Louisiana, Operations
06/30/2025
Germany-Based MTU Maintenance Expands Fort Worth, Texas, MRO Operations
06/30/2025
Cascade Die Casting Group Expands High Point, North Carolina, Manufacturing Operations
06/30/2025
BuildOps Plans Raleigh, North Carolina, Operations
06/30/2025
Most Read
-
20th Annual Area Development Gold and Silver Shovel Awards
Q2 2025
-
First Person: Joe Capes, CEO, LiquidStack
Q2 2025
-
The Legal Limits of DEI in Incentives Agreements, Hiring, and Contracting
Q2 2025
-
From Silicon to Server: Mapping the Data Center Supply Chain
Q2 2025
-
39th Annual Corporate & 21st Annual Consultants Surveys: What Business Leaders and Consultants Are Saying About Site Selection
Q1 2025
-
Rethinking Life Sciences Site Selection in a Resilient and Dynamic Market
Q2 2025
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024